Literature DB >> 10523592

Viability of Trichomonas vaginalis in transport medium.

A L Beverly1, M Venglarik, B Cotton, J R Schwebke.   

Abstract

The ability of Amies gel agar transport medium to maintain the viability of Trichomonas vaginalis was determined by comparing transported vaginal specimens to specimens immediately inoculated into culture medium. The prevalence of trichomonosis in the study population was 26% (68 of 260 women). The immediate inoculation method detected infections in 64 of 68 infected women (sensitivity of 94.1%). The transport method detected 62 of 68 infections (sensitivity of 91.2%). There was no significant difference between the two methods.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10523592      PMCID： PMC85750     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis.

Authors:  J R Schwebke; M F Venglarik; S C Morgan
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 2.  Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel.

Authors:  W Cates
Journal:  Sex Transm Dis       Date:  1999-04       Impact factor: 2.830

3.  An evaluation of an InPouch TV culture method for diagnosing Trichomonas vaginalis infection.

Authors:  K A Borchardt; R F Smith
Journal:  Genitourin Med       Date:  1991-04

4.  Evaluation of a novel specimen transport system (Venturi Transystem) for anaerobic bacteria.

Authors:  M K Hudspeth; D M Citron; E J Goldstein
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

5.  Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens.

Authors:  J N Krieger; M R Tam; C E Stevens; I O Nielsen; J Hale; N B Kiviat; K K Holmes
Journal:  JAMA       Date:  1988-02-26       Impact factor: 56.272

6.  Clinical manifestations of vaginal trichomoniasis.

Authors:  P Wølner-Hanssen; J N Krieger; C E Stevens; N B Kiviat; L Koutsky; C Critchlow; T DeRouen; S Hillier; K K Holmes
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

7.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.

Authors:  M Laga; A Manoka; M Kivuvu; B Malele; M Tuliza; N Nzila; J Goeman; F Behets; V Batter; M Alary
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

8.  Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; S L Hillier; R S Gibbs; D H Martin; D A Eschenbach; R Edelman; J C Carey; J A Regan; M A Krohn; M A Klebanoff; A V Rao; G G Rhoads
Journal:  Sex Transm Dis       Date:  1997-07       Impact factor: 2.830

9.  Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens.

Authors:  C C Olsen; J R Schwebke; W H Benjamin; A Beverly; K B Waites
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948
  9 in total
  7 in total

1.  Viability of Trichomonas vaginalis in Copan universal transport medium and eSwab transport medium.

Authors:  C A Rivers; J R Schwebke
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

2.  Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR.

Authors:  L F Lawing; S R Hedges; J R Schwebke
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

3.  Evaluation of Different Staining Techniques in the Diagnosis of Trichomonas vaginalis Infection in Females of Reproductive Age Group.

Authors:  Razia Khatoon; Noor Jahan; Haris Manzoor Khan; Tamkin Rabbani; Siraj Ahmad
Journal:  J Clin Diagn Res       Date:  2014-12-05

4.  Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection.

Authors:  L Campbell; V Woods; T Lloyd; S Elsayed; D L Church
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

5.  Bacterial Vaginosis and Its Association With Incident Trichomonas vaginalis Infections: A Systematic Review and Meta-Analysis.

Authors:  Arlene C Seña; Linda A Goldstein; Gilbert Ramirez; Austin J Parish; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2021-12-01       Impact factor: 2.830

Review 6.  Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection.

Authors:  Olivia T Van Gerwen; Christina A Muzny
Journal:  F1000Res       Date:  2019-09-20

7.  Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.

Authors:  Christina A Muzny; Jane R Schwebke; Paul Nyirjesy; Gregory Kaufman; Leandro A Mena; Gweneth B Lazenby; Olivia T Van Gerwen; Keonte J Graves; Janeen Arbuckle; Belvia A Carter; Connette P McMahon; Scott Eder; Jackie Shaw; Brajesh Pandey; Steven E Chavoustie
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.